These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19301570)

  • 1. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies.
    O'Brien JM; Lewis DF
    J Reprod Med; 2009 Feb; 54(2):73-87. PubMed ID: 19301570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From concept to practice: the recent history of preterm delivery prevention. Part II: Subclinical infection and hormonal effects.
    Vidaeff AC; Ramin SM
    Am J Perinatol; 2006 Feb; 23(2):75-84. PubMed ID: 16506112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and prevention of recurrent spontaneous preterm birth.
    Spong CY
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):405-15. PubMed ID: 17666618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestational agents for the prevention of preterm birth.
    Lamont RF; Jayasooriya GS
    J Perinat Med; 2009; 37(1):12-4. PubMed ID: 18999914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC; Mol BW; Bruinse HW
    Ned Tijdschr Geneeskd; 2010; 154():A1730. PubMed ID: 20858311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment.
    O'Brien JM
    Am J Perinatol; 2012 Oct; 29(9):665-72. PubMed ID: 22773279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey.
    Ness A; Dias T; Damus K; Burd I; Berghella V
    Am J Obstet Gynecol; 2006 Oct; 195(4):1174-9. PubMed ID: 17000251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
    Thangaratinam S; Coomarasamy A
    Obstet Gynecol; 2005 Jun; 105(6):1483-4; author reply 1484. PubMed ID: 15932848
    [No Abstract]   [Full Text] [Related]  

  • 12. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    Christian MS; Brent RL; Calda P
    J Matern Fetal Neonatal Med; 2007 Feb; 20(2):89-112. PubMed ID: 17437208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth.
    Glover MM; McKenna DS; Downing CM; Smith DB; Croom CS; Sonek JD
    Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of preterm delivery with gestagens].
    Schindler AE
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of progestational agents for preterm birth: lessons from a mouse model.
    Elovitz MA; Mrinalini C
    Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of progesterone to prevent preterm birth at a tertiary care center.
    Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM
    J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of progesterone treatment for the prevention of recurrent preterm birth: identification of obstacles to change.
    Lim AC; Goossens A; Ravelli AC; Boer K; Bruinse HW; Mol BW
    Am J Perinatol; 2010 Mar; 27(3):241-9. PubMed ID: 19823963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance.
    Rittenberg C; Newman RB; Istwan NB; Rhea DJ; Stanziano GJ
    J Reprod Med; 2009 Feb; 54(2):47-52. PubMed ID: 19301566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.